While we don’t ever suggest that investors should base their trading solely on the calendar, there is evidence that the market and many stocks do indeed follow seasonal patterns.  This makes our S&P 500 Stock Seasonality report a useful addition to every investor’s toolbox. Using the last ten years worth of price data, our Stock Seasonality report looks at the average returns for the S&P 500, its eleven sectors, and its 500 individual stocks.  In the report, we highlight the five stocks in each sector that have historically been the best and worst performers over the next two weeks.  For each stock, we also include information such as average returns, the percent of time each stock or sector is positive/outperforms the S&P 500, and its historical performance over the next two weeks for each of the last ten years.  The Stock Seasonality report is published on a weekly basis on Mondays, and it is available to all Bespoke Premium and Bespoke Institutional subscribers.

One stock that we wanted to highlight this week is CVS Health (CVS).  CVS hasn’t been the top performing stock in the S&P 500 during the upcoming two-week period from 2/5 through 2/19, but it has been remarkably consistent.  As shown in the chart below, the stock has been up during this two-week period for ten straight years for a median gain of 3.3%.  Must be a boost from all the flu patients rushing for supplies to help ease the pain!  Along with CVS, there are another six S&P 500 stocks that have been positive during the upcoming two-week period for ten straight years, including two that have seen median gains in excess of 7%.

For active traders, our Stock Seasonality report is an excellent tool to help keep track of the best and worst times of year for the overall market, sectors, and individual stocks.  To see the report and which two stocks have performed even better than EA in the upcoming two-week period, sign up for a monthly Bespoke Premium membership now!